mTORC1
Chr. 1 p36 | |||||||
---|---|---|---|---|---|---|---|
|
Chr. 17 q25.3 | |||||||
---|---|---|---|---|---|---|---|
|
mTORC1, also known as mammalian target of rapamycin complex 1 or mechanistic target of rapamycin complex 1, is a protein complex that functions as a nutrient/energy/redox sensor and controls protein synthesis.[1][2]
mTOR Complex 1 (mTORC1) is composed of the
The role of mTORC1 is to activate translation of proteins.[8] In order for cells to grow and proliferate by manufacturing more proteins, the cells must ensure that they have the resources available for protein production. Thus, for protein production, and therefore mTORC1 activation, cells must have adequate energy resources, nutrient availability, oxygen abundance, and proper growth factors in order for mRNA translation to begin.[4]
Activation at the lysosome
The TSC complex
Almost all of the variables required for protein synthesis affect mTORC1 activation by interacting with the TSC1/TSC2 protein complex.
The Ragulator-Rag complex
mTORC1 interacts at the Ragulator-Rag complex on the surface of the lysosome in response to amino acid levels in the cell.[11][12] Even if a cell has the proper energy for protein synthesis, if it does not have the amino acid building blocks for proteins, no protein synthesis will occur. Studies have shown that depriving amino acid levels inhibits mTORC1 signaling to the point where both energy abundance and amino acids are necessary for mTORC1 to function. When amino acids are introduced to a deprived cell, the presence of amino acids causes Rag GTPase heterodimers to switch to their active conformation.[13] Active Rag heterodimers interact with raptor, localizing mTORC1 to the surface of late endosomes and lysosomes where the Rheb-GTP is located.[14] This allows mTORC1 to physically interact with Rheb. Thus the amino acid pathway as well as the growth factor/energy pathway converge on endosomes and lysosomes. Thus the Ragulator-Rag complex recruits mTORC1 to lysosomes to interact with Rheb.[15][16]
Regulation of the Ragulator-Rag complex
Rag activity is regulated by at least two highly conserved complexes: the "GATOR1" complex containing DEPDC5, NPRL2 and NPRL3 and the ""GATOR2" complex containing Mios, WDR24, WDR59, Seh1L, Sec13.[17] GATOR1 inhibits Rags (it is a GTPase-activating protein for Rag subunits A/B) and GATOR2 activates Rags by inhibiting DEPDC5.
Upstream signaling
Receptor tyrosine kinases
Akt/PKB pathway
Insulin-like growth factors can activate mTORC1 through the
Akt will also phosphorylate PRAS40, causing it to fall off of the Raptor protein located on mTORC1. Since PRAS40 prevents Raptor from recruiting mTORC1's substrates
Furthermore, since insulin is a factor that is secreted by pancreatic
MAPK/ERK pathway
RSK has also been shown to phosphorylate raptor, which helps it overcome the inhibitory effects of PRAS40.[24]
JNK pathway
c-Jun N-terminal kinase (JNK) signaling is part of the mitogen-activated protein kinase (MAPK) signaling pathway essential in stress signaling pathways relating to gene expression, neuronal development, and cell survival. Recent studies have shown there is a direct molecular interaction where JNK phosphorylates Raptor at Ser-696, Thr-706, and Ser-863.[25][26] Therefore, mTORC1 activity is JNK-dependent. Thus, JNK activation plays a role in protein synthesis via subsequent downstream effectors of mTORC1 such as S6 kinase and eIFs.[27]
Wnt pathway
The
Cytokines
Energy and oxygen
Energy status
In order for translation to take place, abundant sources of energy, particularly in the form of ATP, need to be present. If these levels of ATP are not present, due to its hydrolysis into other forms like AMP, and the ratio of AMP to ATP molecules gets too high, AMPK will become activated. AMPK will go on to inhibit energy consuming pathways such as protein synthesis.[30]
AMPK can phosphorylate TSC2 on serine residue 1387, which activates the GAP activity of this complex, causing Rheb-GTP to be hydrolyzed into Rheb-GDP. This inactivates mTORC1 and blocks protein synthesis through this pathway.[31]
AMPK can also phosphorylate Raptor on two serine residues. This phosphorylated Raptor recruits 14-3-3 to bind to it and prevents Raptor from being part of the mTORC1 complex. Since mTORC1 cannot recruit its substrates without Raptor, no protein synthesis via mTORC1 occurs.[32]
LKB1, also known as
Hypoxic stress
When oxygen levels in the cell are low, it will limit its energy expenditure through the inhibition of protein synthesis. Under
Due to the lack of synthesis of ATP in the mitochondria under hypoxic stress or hypoxia, AMPK will also become active and thus inhibit mTORC1 through its processes.[36]
Downstream signaling
mTORC1 activates transcription and translation through its interactions with
4E-BP1
Activated mTORC1 will phosphorylate translation repressor protein
S6K
Previous studies suggest that S6K signaling is mediated by mTOR in a rapamycin-dependent manner wherein S6K is displaced from the eIF3 complex upon binding of mTOR with eIF3.[42] Hypophosphorylated S6K is located on the eIF3 scaffold complex. Active mTORC1 gets recruited to the scaffold, and once there, will phosphorylate S6K to make it active.[18]
mTORC1
Active S6K can bind to the SKAR
S6K1 can also participate in a positive feedback loop with mTORC1 by phosphorylating mTOR's negative regulatory domain at two sites thr-2446 and ser-2448; phosphorylation at these sites appears to stimulate mTOR activity.[48][49]
S6K also can phosphorylate programmed cell death 4 (PDCD4), which marks it for degradation by ubiquitin ligase Beta-TrCP (BTRC). PDCD4 is a tumor suppressor that binds to eIF4A and prevents it from being incorporated into the initiation complex.
Role in disease and aging
mTOR was found to be related to aging in 2001 when the ortholog of S6K, SCH9, was deleted in S. cerevisiae, doubling its lifespan.[50] This greatly increased the interest in upstream signaling and mTORC1. Studies in inhibiting mTORC1 were thus performed on the model organisms of C. elegans, fruitflies, and mice. Inhibition of mTORC1 showed significantly increased lifespans in all model species.[51][52] Disrupting the gut microbiota of infant mice was found to lead to reduced longevity with signaling of mTORC1 implicated as a potential mechanism.[53]
Based on upstream signaling of mTORC1, a clear relationship between food consumption and mTORC1 activity has been observed.
Autophagy
Upon activation, mTORC1 will phosphorylate
mTORC1's ability to inhibit autophagy while at the same time stimulate protein synthesis and cell growth can result in accumulations of damaged proteins and organelles, contributing to damage at the cellular level.[60] Because autophagy appears to decline with age, activation of autophagy may help promote longevity in humans.[61] Problems in proper autophagy processes have been linked to diabetes, cardiovascular disease, neurodegenerative diseases, and cancer.[62]
Lysosomal damage
mTORC1 is positioned on
Reactive oxygen species
Deletion of the TOR1 gene in yeast increases cellular respiration in the mitochondria by enhancing the translation of mitochondrial DNA that encodes for the complexes involved in the electron transport chain.[67] When this electron transport chain is not as efficient, the unreduced oxygen molecules in the mitochondrial cortex may accumulate and begin to produce reactive oxygen species.[68] It is important to note that both cancer cells as well as those cells with greater levels of mTORC1 both rely more on glycolysis in the cytosol for ATP production rather than through oxidative phosphorylation in the inner membrane of the mitochondria.[69]
Inhibition of mTORC1 has also been shown to increase transcription of the
Though AMPK induced eNOS has been shown to regulate mTORC1 in endothelium. Unlike the other cell type in endothelium eNOS induced mTORC1 and this pathway is required for mitochondrial biogenesis.[71]
Stem cells
Conservation of
mTORC1 plays a role in the differentiation and proliferation of
Rapamycin is used clinically as an immunosuppressant and prevents the proliferation of T cells and B cells.
As a biomolecular target
Activators
The
Inhibitors
There have been several dietary compounds that have been suggested to inhibit mTORC1 signaling including
First generation drugs
Rapamycin itself is not very
Second generation drugs
The second generation of inhibitors were created to overcome problems with upstream signaling upon the introduction of first generation inhibitors to the treated cells.
Second generation inhibitors are able to bind to the
Third generation drugs
The third generation of inhibitors were created following the realization that many of the side effects of rapamycin and rapamycin analogs were mediated not as a result of direct inhibition of mTORC1, but as a consequence of off-target inhibition of mTORC2.
There have been over 1,300 clinical trials conducted with mTOR inhibitors since 1970.[110]
References
- ^ PMID 15314020.
- ^ S2CID 4656930.
- PMID 12718876.
- ^ S2CID 17195001.
- S2CID 44444716.
- PMID 26937223.
- PMID 35772404.
- PMID 20071534.
- PMID 23246968.
- PMID 22240970.
- PMID 23361334.
- PMID 22749019.
- PMID 22749019.
- PMID 18497260.
- S2CID 25954873.
- PMID 21785113.
- PMID 23723238.
- ^ S2CID 30790160.
- ^ PMID 21531565.
- PMID 17517883.
- PMID 23471659.
- PMID 23085539.
- S2CID 18663447.
- S2CID 15088729.
- PMID 22493283.
- PMID 21320501.
- PMID 24333448.
- ^ PMID 22325146.
- PMID 22899934.
- S2CID 38533515.
- PMID 21892142.
- PMID 18439900.
- PMID 22353783.
- PMID 20176937.
- PMID 15545625.
- PMID 22390198.
- PMID 21436840.
- PMID 21906675.
- PMID 10216943.
- PMID 16540693.
- PMID 22168162.
- S2CID 11118504.
- PMID 11914378.
- ^ S2CID 36947968.
- PMID 9445476.
- S2CID 2528173.
- S2CID 13437701.
- PMID 15899889.
- PMID 15905173.
- S2CID 44756177.
- PMID 22560223.
- PMID 19587680.
- S2CID 237306510.
- S2CID 42188272.
- PMID 20139716.
- ^ PMID 23406030.
- PMID 23072311.
- PMID 22025673.
- PMID 22257882.
- S2CID 13379878.
- PMID 10806201.
- PMID 16247498.
- ^ PMID 29625033.
- PMID 25542097.
- S2CID 17229119.
- PMID 19061483.
- PMID 17403371.
- PMID 16115017.
- PMID 21325052.
- PMID 22810811.
- PMID 26989010.
- PMID 15995659.
- ^ PMID 15254238.
- PMID 15485918.
- ^ PMID 19934433.
- PMID 21791526.
- PMID 22888331.
- PMID 19543266.
- ^ PMID 20536567.
- ^ PMID 29899972.
- PMID 20851890.
- PMID 22993301.
- PMID 1102508.
- PMID 17275731.
- PMID 16603397.
- PMID 22461615.
- PMID 25652038.
- ^ PMID 21216931.
- PMID 23352077.
- PMID 26463117.
- PMID 32759497.
- S2CID 24753934.
- PMID 22910420.
- PMID 21763970.
- PMID 22687453.
- PMID 22475451.
- S2CID 18525093.
- ^ PMID 21333749.
- PMID 20203102.
- S2CID 215803320.
- PMID 21651476.
- S2CID 207474033.
- S2CID 22677288.
- PMID 22461615.
- ISBN 978-1-68108-233-2.
- PMID 31324799.
- PMID 29236692.
- PMID 29416044.
- PMID 31231029.
- PMID 23325216.
External links
- mTORC1+complex,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)